Compare Novavax Inc (NVAX) vs VICI Properties Inc (VICI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs VICI Properties Inc — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while VICI Properties Inc trades at $25.98 (market cap $28.61B). The key difference: VICI Properties Inc is far larger — about 21.8× Novavax Inc's market cap, and VICI Properties Inc pays a 6.93% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | VICI | |
|---|---|---|
Market Cap | $1.31B | $28.61B |
Sector | Health | Real Estate |
52-Week High | $11.19 | $33.78 |
52-Week Low | $6.22 | $25.94 |
Enterprise Value | $889.30M | $46.16B |
Dividend Yield | — | 6.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →
